A)Stratify patients with breast cancer into groups predictive of response to therapy. B)Determine the most relevant treatment for individual patients based on their genomic "signature." C)Predict the likelihood of disease recurrence in individuals based on gene expression signatures. D)A,B,and C. E)None of the above.